NASDAQ: AZRX

SEARCH

SIGN UP

AzurRx Logo
  • About
      • Back
      • Company Profile
      • Management Team
      • Board of Directors
      • Scientific Advisory Board
  • Science & Technology
      • Back
      • Overview
      • Programs
      • Development Pipeline
      • Cystic Fibrosis
      • Chronic Pancreatitis
      • Immune Checkpoint Inhibitor Colitis
      • COVID-19 GI Infections
      • Non-Systemic Biologics
      • Digestive Enzymes
      • Niclosamide
  • Investors
      • Back
      • Press Releases
          • Back
          • 2021
          • 2020
          • 2019
          • 2018
          • 2017
          • 2016
          • 2015
          • 2014
      • Events
      • Presentations
      • Regulatory Filings
      • Financial Statements
          • Back
          • 2020
              • Back
              • Q2 2020
              • Q1 2020
          • 2019
              • Back
              • Q4 2019
              • Q3 2019
              • Q2 2019
              • Q1 2019
          • 2018
              • Back
              • Q4 2018
              • Q3 2018
              • Q2 2018
              • Q1 2018
          • 2017
              • Back
              • Q4 2017
              • Q3 2017
              • Q2 2017
              • Q1 2017
          • 2016
              • Back
              • Q4 2016
              • Q3 2016
      • Stock Info
      • Analyst Coverage
      • Corporate Governance
      • Contact Us
  • News and Media
      • Back
      • Podcasts
      • Media Interviews
  • Clinical Trials
      • Back
      • Ongoing Clinical Trials
      • Completed Clinical Trials
      • Clinical Publications
  • Collaborations
      • Back
      • Partnering with AzurRx
  • Contact
      • Back
      • Contact Us
      • Subscribe
  • Home
  • Science & Technology
  • Development Pipeline

Menu

  • Overview
  • Programs
  • Development Pipeline
  • Cystic Fibrosis
  • Chronic Pancreatitis
  • Immune Checkpoint Inhibitor Colitis
  • COVID-19 GI Infections
  • Non-Systemic Biologics
  • Digestive Enzymes
  • Niclosamide

Development Pipeline

development-pipeline.jpg

 

MS1819 pipeline

 

  • About
  • Science & Technology
  • Investors
  • News and Media
  • Clinical Trials
  • Collaborations
  • Contact

Contact Us

AzurRx BioPharma, Inc.

1615 South Congress Avenue
Suite 103
Delray Beach, Florida 33445 

Tel: 646-699-7855
info@azurrx.com

AzurRx SAS

Jardin des Entreprises, Bat 1
290, Chemin de Saint-Dionisy
30980 Langlade, France

Tel: +33 (0)4 66 67 08 16

SiteMap Ⓒ 2021 AzurRx All Rights Reserved.